July 15, 2021 |
Colombian vaccination company VaxThera could look for partners to help fund clinical trials next year, building on an initial $54 million investment from local financial services firm Grupo Sura, founder and CEO Jorge Osorio said in an interview with LatinFinance.
"We have support for the first phase, but we are looking for support for additional phases," Osorio said.
With the money from Sura, VaxThera plans to build a production facility either on the outskirts of Bogotá or Medellín with the ai
Colombian vaccination company will use $54 mln from Sura to build a production plant, but it could need more investments for later stages, CEO says